第六次儿科机械循环支持机构间登记(Pedimacs)报告:胸外科医师学会Pedimacs年度报告
该报告基于2012年9月19日至2021年12月31日北美42家医院1109例(<19岁)患者的1355台心室辅助装置(VAD),分析基础病因、装置类型及结局。心肌病最常见(59%),植入后6个月有利结局达84%,可植入连续流(IC)VAD最高(92%),旁体脉冲式(PP)居中,旁体连续流(PC)最低(69%);非胃肠道出血(14%)和神经功能障碍(11%[卒中4%])最常见,卒中与出血对总生存有负面影响(P分别=.002和<.001)。
要点
- 心肌病为最常见基础病因(59%),其次为先天性心脏病(25%)和心肌炎(9%)。
- 植入后6个月有利结局(移植、恢复或带装置存活)达84%,IC VAD组92%,PC VAD组69%。
- 非胃肠道出血(14%)和神经功能障碍(11%,其中卒中4%)在植入后2周内最常见。
核心结论
- 第六次Pedimacs报告显示儿科领域持续演变,心脏生理复杂性和解剖限制要求使用多种类型装置(PC、PP、IC)。
- 本报告对每种装置类型的详细分析为推进这一具有挑战性且脆弱人群的照护提供了有价值的信息。
研究设计与样本
- 登记研究,基于2012年9月19日至2021年12月31日北美42家医院1109例(<19岁)患者的1355台装置数据。
主要发现
- 心肌病为最常见基础病因(59%),先天性心脏病25%,心肌炎9%。
- 装置类型:可植入连续流(IC)VAD最常见(40%),旁体脉冲式(PP)28%,旁体连续流(PC)26%。
- PC组基线更年轻、体型更小、更复杂(即先天性心脏病)且植入时病情更重(P < .0001)。
- 植入后6个月有利结局(移植、恢复或带装置存活)达84%,IC VAD组最高(92%),PC VAD组最低(69%)。
- 非胃肠道出血发生率14%,神经功能障碍11%(卒中4%),卒中与出血对总生存有负面影响(P = .002和P < .001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs), supported by The Society of Thoracic Surgeons, provides detailed information on pediatric patients supported with ventricular assist devices (VADs). METHODS: From September 19, 2012, to December 31, 2021, there were 1355 devices in 1109 patients (<19 years) from 42 North American Hospitals. RESULTS: Cardiomyopathy was the most common underlying cause (59%), followed by congenital heart disease (25%) and myocarditis (9%). Regarding device type, implantable continuous (IC) VADs were most common at 40%, followed by paracorporeal pulsatile (PP; 28%) and paracorporeal continuous (PC; 26%). Baseline demographics differed, with the PC cohort being younger, smaller, more complex (ie, congenital heart disease), and sicker at implantation (P < .0001). At 6 months after VAD implantation, a favorable outcome (transplantation, recovery, or alive on device) was achieved in 84% of patients, which was greatest among those on IC VADs (92%) and least for PC VADs (69%). Adverse events were not uncommon, with nongastrointestinal bleeding (incidence of 14%) and neurologic dysfunction (11% [stroke, 4%]), within 2 weeks after implantation being the most prevalent. Stroke and bleeding had negative impacts on overall survival (P = .002 and P < .001, respectively). CONCLUSIONS: This Sixth Pedimacs Report demonstrates the continued evolution of the pediatric field. The complexity of cardiac physiologies and anatomic constraint mandates the need for multiple types of devices used (PC, PP, IC). Detailed analyses of each device type in this report provide valuable information to further advance the care of this challenging and vulnerable population.
引用
- Adachi I, Peng DM, Hollander SA, et al. Sixth Annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) Report: The Society Of Thoracic Surgeons Pedimacs Annual Report. Ann Thorac Surg. 2022. PMID: 36402175. doi:10.1016/j.athoracsur.2022.10.042
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。